🇺🇸 FERRIC CITRATE ANHYDROUS in United States

278 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Shunt Stenosis — 63 reports (22.66%)
  2. Shunt Occlusion — 44 reports (15.83%)
  3. Pneumonia — 30 reports (10.79%)
  4. Fall — 28 reports (10.07%)
  5. Cardiac Failure — 24 reports (8.63%)
  6. Cerebral Infarction — 21 reports (7.55%)
  7. Diarrhoea — 19 reports (6.83%)
  8. Peripheral Arterial Occlusive Disease — 18 reports (6.47%)
  9. Exposure During Pregnancy — 16 reports (5.76%)
  10. Death — 15 reports (5.4%)

Source database →

FERRIC CITRATE ANHYDROUS in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is FERRIC CITRATE ANHYDROUS approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for FERRIC CITRATE ANHYDROUS in United States?

Marketing authorisation holder not available in our data.